Circulating kidney injury molecule-1 (KIM-1) and association with outcome to adjuvant immunotherapy in renal cell carcinoma
Brian I. Rini, Laurence Albigès, Xiaobin Tang, Hartmut Koeppen, Axel Bex, Cynthia Suárez, Robert G. Uzzo, Habib Hamidi, Zoe J. Assaf, S. Dubey, E.T. Goluboff, C. Carter, S.K. Pal, Romain Banchereau, Wenxin Xu, Mahrukh Huseni
Topics & Concepts
MedicineRenal cell carcinomaAdjuvantImmunotherapyOncologyInternal medicineCancerRenal cell carcinoma treatmentGalectins and Cancer BiologyCancer Immunotherapy and Biomarkers